ArticleThe Journal of experimental medicine2020
Lipocalin-2 counteracts metabolic dysregulation in obesity and diabetes.
Ioanna Mosialou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
71 papers cite itlatest 60 shown
this paperpooled itcites it